These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7482406)

  • 1. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta 2-glycoprotein I and anti-beta 2-glycoprotein I.
    Schousboe I; Rasmussen MS
    Thromb Haemost; 1995 May; 73(5):798-804. PubMed ID: 7482406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).
    Schousboe I
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextran sulphate inhibits phospholipid and sulphatide mediated autoactivation of factor XII.
    Schousboe I; Rasmussen MS; Lintner R
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):503-9. PubMed ID: 7841305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
    Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
    J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to beta 2-glycoprotein I inhibit phospholipid dependent coagulation reactions.
    Brandt JT
    Thromb Haemost; 1993 Oct; 70(4):598-602. PubMed ID: 8115986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V; Biasiolo A; Rampazzo P; Brocco T
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces.
    Arnout J; Wittevrongel C; Vanrusselt M; Hoylaerts M; Vermylen J
    Thromb Haemost; 1998 Jan; 79(1):79-86. PubMed ID: 9459328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-beta 2 glycoprotein I antibodies in centenarians.
    Meroni PL; Mari D; Monti D; Coppola R; Capri M; Salvioli S; Tincani A; Gerli R; Franceschi C
    Exp Gerontol; 2004 Oct; 39(10):1459-65. PubMed ID: 15501015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
    Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
    Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
    Sheng Y; Kandiah DA; Krilis SA
    J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticardiolipin antibodies block the inhibition by beta 2-glycoprotein I of the factor Xa generating activity of platelets.
    Shi W; Chong BH; Hogg PJ; Chesterman CN
    Thromb Haemost; 1993 Aug; 70(2):342-5. PubMed ID: 8236146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids.
    Pengo V; Balestrieri G; Tincani A; Spatola L; Biasiolo A; Brocco T
    Thromb Haemost; 1997 Jan; 77(1):123-6. PubMed ID: 9031461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta 2 glycoprotein-I inhibits factor XII activation on triglyceride rich lipoproteins: the effect of antibodies from plasma of patients with antiphospholipid syndrome.
    McNally T; Mackie IJ; Isenberg DA; Machin SJ
    Thromb Haemost; 1996 Aug; 76(2):220-5. PubMed ID: 8865535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiphospholipid and anti beta 2-glycoprotein I antibodies].
    Arvieux J; Roussel B; Colomb MG
    Ann Biol Clin (Paris); 1994; 52(5):381-5. PubMed ID: 7856939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
    Pengo V; Biasiolo A; Fior MG
    Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfatides: targets for anti-phospholipid antibodies.
    Merten M; Motamedy S; Ramamurthy S; Arnett FC; Thiagarajan P
    Circulation; 2003 Oct; 108(17):2082-7. PubMed ID: 14530197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional coagulation test to identify anti-beta2-glycoprotein I dependent lupus anticoagulants.
    Devreese KM
    Thromb Res; 2007; 119(6):753-9. PubMed ID: 16842842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.